Carrier diagnosis and prevention of sickle cell disease and thalassemia major: Recommendations of the workgroup Hemoglobinopathies;Dragerschapdiagnostiek en preventie van sikkelcelziekte en thalassemia major; aanbevelingen van de werkgroep Hemoglobinopathieën

Nederlands Tijdschrift voor Klinische Chemie en Laboratoriumgeneeskunde

Volumn 31, Issue 4, 2006, Pages 301-305

  Giordano, P C ^a   Smit, J W ^b   Herruer, M ^b   Huisman, W ^b   Pouwels, J G J ^b   Verhoef, N ^b   Idema, R N ^b   Wijermans, P ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GENETIC RISK; HEALTH CARE; HEALTH PROGRAM; HEMOGLOBINOPATHY; HUMAN; LABORATORY DIAGNOSIS; MEDICAL INFORMATION; NETHERLANDS; PRENATAL DIAGNOSIS; PROPHYLAXIS; SHORT SURVEY; SICKLE CELL ANEMIA; THALASSEMIA;

EID: 34248195808     PISSN: 15708306     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (30)

1. Giordano PC. Hemoglobinopathieën in Nederland. Diagnostiek, epidemiologic en preventie. Dissertatie 1998. ISBN nummer 90-9011949-3
2. Losekoot M, Fodde R, Harteveld CL, Heeren H van, Giordano PC, Bernini LF. Denaturing gradient gel electrophoresis and direct sequencing of amplified genomic DNA: a rapid and reliable diagnostic approach to beta thalassemia. British J Haematol 1990; 76: 269-276.
3. Silvestroni E, Bianco I. Screening for microcytemia in Italy: analysis of data collected in the past 30 years. Am J Hum Genet. 1975; 27: 198-212.
4. Kuliev AM. The WHO control program for hereditary anemias. Birth Defects Orig Artie Ser 1988; 23: 383-394.
5. Cao A, Furbetta M, Galanello R, Melis MA, Angius A, Ximenes A, Rosatelli C, Ruggeri R, Addis M, Tuveri T, Falchi AM, Paglietti E, Scalas MT. Prevention of homozygous beta-thalassemia by carrier screening and prenatal diagnosis in Sardinia. Am J Hum Genet 1981; 33: 592-605.
6. Lena-Russo D, Erny N, Serradimigni F, Badens C, Aubinaud M, Merono F, Paolasso C, Mattei JF, Giraud F. Genetic hemoglobin diseases. Prevention at centers for family planning and education of maternal-child protection in Marseille. Presse Med. 1996; 25: 151-153.
7. Angastiniotis M, Kyriakidou S, Hadjiminas M. The Cyprus Thalassemia Control Program. Birth Defects Orig Artic Ser 1988; 23: 417-432.
8. Longinotti M, Pistidda P, Oggiano L, Guiso L, Frogheri L, Dore F, Pardini S, Bonfigli S, Rimini E, Angioni S, et al. A 12-year preventive program for beta-thalassemia in Northern Sardinia. Clin Genet 1994; 46: 238-243.
9. Lipkin M Jr, Fisher L, Rowley PT, Loader S, Iker HP. Genetic counseling of asymptomatic carriers in a primary care setting. The effectiveness of screening and counseling for beta-thalassemia trait. Ann Intern Med 1986; 105: 115-123.
10. Keskin A, Turk T, Polat A, Koyuncu H, Saracoglu B. Premarital screening of beta-thalassemia trait in the province of Denizli, Turkey. Acta Haematol 2000; 104: 31-33.
11. Koren A, Zalman L, Palmor H, Ekstein E, Schneour Y, Schneour A, Shalev S, Rachmilewitz EA, Filon D, Openhaim A. The prevention programs for beta thalassemia in the Jezreel and Eiron valleys: results of fifteen years experience Harefuah. 2002; 141: 938-943, 1210. Hebrew.
12. Lorey F, Cunningham G, Vichinsky EP, Lubin BH, Witkowska HE, Matsunaga A, Azimi M, Sherwin J, Eastman J, Farina F, Waye JS, Chui DH. Universal newborn screening for Hb H disease in California. Genet Test 2001; 5: 93-100.
13. Hendy J. Preventation of thalassemia in Australia. Southeast Asian J Trop Med Public Health 1999; 30 Suppl 2: 94-6.
14. Jaovisidha A, Ajjimarkorn S, Panburana P, Somboonsub O, Herabutya Y, Rungsiprakarn R. Prevention and control of thalassemia in Ramathibodi Hospital, Thailand. Southeast Asian J Trop Med Public Health. 2000; 31: 561-565.
15. Perera DM, Gunasekara D, Wijekoon A, Petrou M. Thalassaemia control in developing countries - the Sri Lankan perspective. Ceylon Med J 2000; 45: 12-16. Review.
16. Kor-anantakul O, Suwanrath CT, Leetanaporn R, Suntharasaj T, Liabsuetrakul T, Rattanaprueksachart R. Prenatal diagnosis of thalassemia in Songklanagarind Hospital in southern Thailand. Southeast Asian J Trop Med Public Health 1998; 29: 795-800.
17. Setianingsih I I, Williamson R, Marzuk S, Harahap A, Tamam M, Forrest S. Molecular Basis of beta-Thalassemia in Indonesia: Application to Prenatal Diagnosis. Mol Diagn 1998; 3: 11-19.
18. Capua A. The Montreal Thalassemia Screening program. Response of the high school students. Ann N Y Acad Sci 1998; 850: 401-403.
19. Wanapirak C, Tongsong T, Sirivatanapa P, Sa-nguansermsri T, Sekararithi R, Tuggapichitti A. Prenatal strategies for reducing severe thalassemia in pregnancy. Int J Gynaecol Obstet 1998; 60: 239-244.
20. Ko TM, Xu X. Molecular study and prenatal diagnosis of alpha- and beta-thalassemias in Chinese. J Formos Med Assoc 1998; 97: 5-15. Review.
21. Ghanei M, Adibi P, Movahedi M, Khami MA, Ghasemi RL, Azarm T, Zolfaghari B, Jamshidi HR, Sadri R. Pre-marriage prevention of thalassaemia: report of a 100,000 case experience in Isfahan. Public Health 1997; 111: 153-156.
22. Shafer FE, Lorey F, Cunningham GC, Klumpp C, Vichinsky E, Lubin B. Newborn screening for sickle cell disease: 4 years of experience from California's newborn screening program. J Pediatr Hematol Oncol 1996; 18: 36-41.
23. Pravatmuang P, Tiloklurs M, Suannum M, Chaipat C. Phitsanulok population: the highest incidence of hemoglobin E in the northern provinces of Thailand and PND counseling. Southeast Asian J Trop Med Public Health 1995; 26 Suppl 1: 266-270.
24. Giordano PC, Harteveld CL. Hemoglobinopathies in immigrant populations: setting up prevention strategies in The Netherlands. Proceedings from the 7th meeting of the European Haematological Association. Monduzzi Editore, ISBN 88-323-2606-X.
25. Modell B, Harris R, Lane B, Khan M, Darlison M, Petrou M, Old J, Layton M, Varnavides L. Informed choice in genetic screening for thalassemia during pregnancy: audit from a national confidential inquiry. Brit Med J 2000; 320: 337-341.
26. Clark BE, Thein SL. Molecular diagnosis of haemoglobin disorders. Clin Lab Hematol 2004; 26: 159-176.
27. Giordano PC. Preventie van Cystische Fibrose en hemoglobinopathie in de huisartspraktijk. Hoofdstuk in Vorderingen en praktijk onder redactie van M.P. Springer. Boerhaave editie ISBN 90-6767-510-5.
28. Steinberg MH, Forget BG, Higgs DR, Nagel RL. Disorders of Hemoglobin. Cambridge University Press. 2001.
29. Giordano PC, Breuning MH. Van gen naar ziekte; van hemoglobinegenen naar thalassemie en sikkelcelanemie. Ned Tijdschr Geneeskd 2000; 144: 1910-1913.
30. Karnon J, Zeuner D, Brown J, Ades AE, Wonke B, Modell B. Lifetime treatment costs of beta-thalassaemia major. Clin Lab Haematol 1999; 21: 377-385.